Moderna asks health regulators to authorize its covid-19 vaccine, Arizona, Wisconsin certify narrow victories for Joe Biden, and Louisville coffee shop customer pays it forward with random act of kindness.
The initial doses of Pfizer and BioNTech’s Covid-19 vaccines could go out next month, if the FDA grants emergency authorization. There are also three other promising vaccine candidates in the pipeline from AstraZeneca, Moderna, and Johnson & Johnson. The process of distributing the vaccine to the 330 million people living in the U.S., however, could prove a logistical challenge. Here’s a look at how the federal government plans to do it.
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic. The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 trial participants contracted Covid-19, including just five who were given the coronavirus jab. While the data was published via a press release, it includes significant details that remain unclear around the Pfizer-BioNTech vaccine – which uses the same mRNA technology to target the coronavirus spike protein and an immune response.
Boomers Daily 